* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
This filing lists securities holdings reported on the form 13F filed on 16 Feb 2016 pursuant to a request for confidential treatment and for which confidential treatment expired on 16 May 2016.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Kevin J. O'Connor
Authorized Person
Stamford, Connecticut
16 May 2016
Confidential treatment was not granted for this filing by the Securities and Exchange Commission, but confidentiality was in effect until the expiration of the requested period pursuant to Rule 24b-2 under the Securities Exchange Act of 1934. Positions that are exempt from reporting under Special Instruction 10 to the Form 13F are excluded from this report. However, positions that would not be exempt when aggregated with positions of the same security held by (i) the Other Included Managers or (ii) certain affiliates of the Reporting Manager and reported on their own Forms 13F, are listed herein.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.